This site is intended for health professionals only

Tuesday 22 October 2019

Juan Gomez-Reino MD

Articles by this author

Tue 2 October
Tue 2 October
Progress in treating rheumatoid arthritis has been achieved with Janus kinase inhibitors, orally available disease-modifying anti-rheumatic drugs targeting the intracellular kinase JAK and having similar efficacies to biologics